| Nome |
# |
|
Breast cancer stem cell antigens as targets for immunotherapy, file e27ce42f-4edf-2581-e053-d805fe0acbaa
|
1.239
|
|
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy, file e27ce42f-5a65-2581-e053-d805fe0acbaa
|
482
|
|
NK cells control breast cancer and related cancer stem cell hematological spread, file e27ce42b-cf9d-2581-e053-d805fe0acbaa
|
477
|
|
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells, file e27ce428-177e-2581-e053-d805fe0acbaa
|
438
|
|
Cluster analysis of quantitative parametric maps from DCE-MRI: Application in evaluating heterogeneity of tumor response to antiangiogenic treatment, file e27ce428-4281-2581-e053-d805fe0acbaa
|
341
|
|
A plant-expressed conjugate vaccine breaks CD4+ tolerance and induces potent immunity against metastatic Her2+ breast cancer, file e27ce429-ebdd-2581-e053-d805fe0acbaa
|
301
|
|
'In Vitro', 'In Vivo' and 'In Silico' Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector, file e27ce42c-56b9-2581-e053-d805fe0acbaa
|
294
|
|
Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging, file e27ce429-b0bb-2581-e053-d805fe0acbaa
|
290
|
|
DNA vaccination against membrane-bound Kit ligand: A new approach to inhibiting tumour growth and angiogenesis, file e27ce426-f2a7-2581-e053-d805fe0acbaa
|
279
|
|
Preclinical vaccines against mammary carcinoma, file e27ce426-f7f7-2581-e053-d805fe0acbaa
|
267
|
|
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors, file e27ce428-1164-2581-e053-d805fe0acbaa
|
265
|
|
Cancer stem cell antigens as targets for new combined anti-cancer therapies, file e27ce431-33b9-2581-e053-d805fe0acbaa
|
250
|
|
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer, file e27ce428-13c6-2581-e053-d805fe0acbaa
|
245
|
|
The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2+ mammary cancer, file e27ce428-0552-2581-e053-d805fe0acbaa
|
239
|
|
Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration, file e27ce42a-9f63-2581-e053-d805fe0acbaa
|
238
|
|
Novel insights into Notum and glypicans regulation in colorectal cancer, file e27ce427-96ca-2581-e053-d805fe0acbaa
|
228
|
|
The Fourteenth International Conference on Progress in Vaccination Against Cancer (PIVAC-14), September 24–26, 2014, Rome, Italy: rethinking anti-tumor vaccines in a new era of cancer immunotherapy, file e27ce428-106e-2581-e053-d805fe0acbaa
|
226
|
|
Xenogene vaccination in the therapy of cancer., file e27ce427-0a1d-2581-e053-d805fe0acbaa
|
224
|
|
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo, file e27ce42c-53dd-2581-e053-d805fe0acbaa
|
206
|
|
Consensus nomenclature for CD8(+) T cell phenotypes in cancer, file e27ce428-193d-2581-e053-d805fe0acbaa
|
205
|
|
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors., file e27ce426-e743-2581-e053-d805fe0acbaa
|
203
|
|
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries, file e27ce42b-63d1-2581-e053-d805fe0acbaa
|
203
|
|
CSPG4: a prototype oncoantigen for translational immunotherapy studies, file e27ce42b-dc38-2581-e053-d805fe0acbaa
|
200
|
|
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy, file e27ce431-ecd8-2581-e053-d805fe0acbaa
|
195
|
|
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results, file e27ce427-86ab-2581-e053-d805fe0acbaa
|
188
|
|
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues, file e27ce428-09f6-2581-e053-d805fe0acbaa
|
185
|
|
Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer., file e27ce427-0a1c-2581-e053-d805fe0acbaa
|
183
|
|
Chondroitin sulfate proteoglycan 4: A biomarker and potential immunotherapeutic target for canine malignant melanoma, file e27ce426-d044-2581-e053-d805fe0acbaa
|
182
|
|
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents, file e27ce42a-90c1-2581-e053-d805fe0acbaa
|
178
|
|
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging, file e27ce42c-0ea9-2581-e053-d805fe0acbaa
|
176
|
|
The Promise of Preventive Cancer Vaccines, file e27ce428-0bd6-2581-e053-d805fe0acbaa
|
175
|
|
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers., file e27ce426-f23a-2581-e053-d805fe0acbaa
|
171
|
|
Classification of current anticancer immunotherapies, file e27ce427-0a1b-2581-e053-d805fe0acbaa
|
171
|
|
ErbB2 receptor over-expression improves post-traumatic peripheral nerve regeneration in adult mice., file e27ce426-df07-2581-e053-d805fe0acbaa
|
166
|
|
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy, file e27ce431-f43c-2581-e053-d805fe0acbaa
|
166
|
|
Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies., file e27ce427-0a21-2581-e053-d805fe0acbaa
|
164
|
|
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model, file e27ce428-cc5c-2581-e053-d805fe0acbaa
|
161
|
|
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer, file e27ce42b-a164-2581-e053-d805fe0acbaa
|
157
|
|
Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells, file e27ce427-0f51-2581-e053-d805fe0acbaa
|
156
|
|
Vaccination with ENO1 DNA Prolongs Survival of Genetically Engineered Mice with Pancreatic Cancer., file e27ce42a-1a94-2581-e053-d805fe0acbaa
|
153
|
|
RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells, file e27ce42b-2a21-2581-e053-d805fe0acbaa
|
153
|
|
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2., file e27ce426-f7f4-2581-e053-d805fe0acbaa
|
148
|
|
A mathematical-biological joint effort to investigate the tumor-initiating ability of cancer stem cells., file e27ce426-f3da-2581-e053-d805fe0acbaa
|
140
|
|
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice, file e27ce426-f748-2581-e053-d805fe0acbaa
|
138
|
|
State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues?, file e27ce426-f837-2581-e053-d805fe0acbaa
|
136
|
|
Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis, file e27ce42b-a153-2581-e053-d805fe0acbaa
|
134
|
|
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma, file e27ce42e-4077-2581-e053-d805fe0acbaa
|
129
|
|
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma, file e27ce42e-a384-2581-e053-d805fe0acbaa
|
128
|
|
Multi-level model for the investigation of oncoantigen- driven vaccination effect, file e27ce426-e16b-2581-e053-d805fe0acbaa
|
126
|
|
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients., file e27ce42a-7355-2581-e053-d805fe0acbaa
|
126
|
|
Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns, file e27ce42c-a15e-2581-e053-d805fe0acbaa
|
116
|
|
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research, file e27ce434-b112-2581-e053-d805fe0acbaa
|
111
|
|
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy, file e27ce42e-1913-2581-e053-d805fe0acbaa
|
110
|
|
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases, file e27ce434-fca2-2581-e053-d805fe0acbaa
|
103
|
|
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential, file e27ce431-3500-2581-e053-d805fe0acbaa
|
93
|
|
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression, file e27ce430-8a17-2581-e053-d805fe0acbaa
|
88
|
|
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer, file e27ce431-8051-2581-e053-d805fe0acbaa
|
78
|
|
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines, file e27ce430-f1e8-2581-e053-d805fe0acbaa
|
74
|
|
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer, file e27ce431-16e8-2581-e053-d805fe0acbaa
|
71
|
|
2011: the immune hallmarks of cancer., file e27ce428-56ea-2581-e053-d805fe0acbaa
|
69
|
|
Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy, file e27ce434-ac9b-2581-e053-d805fe0acbaa
|
67
|
|
Ultrasound-activated decafluoropentane-cored and chitosan-shelled nanodroplets for oxygen delivery to hypoxic cutaneous tissues, file e27ce429-8662-2581-e053-d805fe0acbaa
|
66
|
|
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota, file e27ce430-e93c-2581-e053-d805fe0acbaa
|
65
|
|
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas, file e27ce431-372d-2581-e053-d805fe0acbaa
|
65
|
|
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis, file e27ce431-4d8f-2581-e053-d805fe0acbaa
|
63
|
|
Erbb2 DNA vaccine combined with Treg cell deletion enhances antibody response and reveals latent low-avidity T cells. Potential and limits of its therapeutic efficacy., file e27ce42a-f97f-2581-e053-d805fe0acbaa
|
58
|
|
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies, file e27ce431-f030-2581-e053-d805fe0acbaa
|
54
|
|
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2, file e27ce427-a159-2581-e053-d805fe0acbaa
|
48
|
|
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis, file e27ce432-4f9d-2581-e053-d805fe0acbaa
|
44
|
|
DNA vaccination against oncoantigens: a promise., file e27ce426-e857-2581-e053-d805fe0acbaa
|
39
|
|
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?, file e27ce435-490c-2581-e053-d805fe0acbaa
|
38
|
|
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models, file 7bb3f3bd-c9be-4a5c-86fa-872eecc8e43b
|
37
|
|
Multi-level model for the investigation of oncoantigen-driven vaccination effect, file e27ce426-f213-2581-e053-d805fe0acbaa
|
32
|
|
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer, file 8589dbe8-9d39-4c05-836d-9537a38c5e89
|
31
|
|
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer, file be6b59bb-0196-468b-89a1-35247ffc654b
|
31
|
|
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters, file e27ce434-36df-2581-e053-d805fe0acbaa
|
30
|
|
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis, file e27ce434-d031-2581-e053-d805fe0acbaa
|
22
|
|
The importance of comparative oncology in translational medicine., file 698efd4c-bfad-4f54-97b9-fb59efe64306
|
21
|
|
The Amot/integrin protein complex transmits mechanical forces required for vascular expansion, file e27ce435-1577-2581-e053-d805fe0acbaa
|
14
|
|
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial, file 1c78b5b0-6c22-4e7c-bc98-8bf645b45822
|
13
|
|
Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+mammary cancer, file e27ce435-2dc9-2581-e053-d805fe0acbaa
|
13
|
|
Improving Osteosarcoma Treatment: Comparative Oncology in Action, file 0e07d156-337f-4b95-b090-20c988784134
|
12
|
|
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment, file 2d26e306-35f1-4949-9f8b-90e1fc0b28c9
|
12
|
|
The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy, file 731174f4-1b8a-49b2-948f-8e1a36f6ef65
|
12
|
|
Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity, file c2996805-55f3-42f6-8360-2d3adb00e537
|
12
|
|
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010–2020), file b24cc6d8-5bfd-4520-bfc5-8181daf9d401
|
10
|
|
Ultrasound-activated decafluoropentane-cored and chitosan-shelled nanodroplets for oxygen delivery to hypoxic cutaneous tissues, file e27ce427-adfa-2581-e053-d805fe0acbaa
|
9
|
|
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis, file c6c2b670-e683-4a0a-bd0a-bf10da08bb2d
|
7
|
|
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA, file e27ce427-0a24-2581-e053-d805fe0acbaa
|
7
|
|
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy, file 0ea4623c-a566-4b23-ab56-d7aa852acdae
|
6
|
|
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter, file e27ce432-4ca8-2581-e053-d805fe0acbaa
|
6
|
|
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity, file e27ce432-bd55-2581-e053-d805fe0acbaa
|
6
|
|
Antitumor immunization of mothers delays tumor development in cancer-prone offspring, file 114b0b3a-5455-478e-b367-d7e3a618d7e5
|
5
|
|
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells, file 1cf1af2a-e5a2-4082-8051-009d7941ebed
|
5
|
|
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013, file 4836d176-ab40-4f5e-9216-b0f8f054956a
|
5
|
|
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer, file e27ce432-4c23-2581-e053-d805fe0acbaa
|
5
|
|
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response, file f15604fd-0a1f-44d2-9ad9-610518d1e734
|
5
|
|
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease, file f6fc7ba2-e2ea-453c-9af5-5c8faeee1124
|
5
|
|
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice, file 1db3155f-bc82-4e51-9497-d4a26c52c50b
|
4
|
|
Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells, file e27ce427-4b06-2581-e053-d805fe0acbaa
|
4
|
| Totale |
13.526 |